Skip to content

Our publications

Since its inception, Inovarion has contributed to the completion of high-level research projects. Our scientists have actively participated to studies resulting in publications in prestigious, high-impact journals. These publications span a wide range of fields within biology, driving innovation and fostering progress across numerous therapeutic and scientific domains.

See all on Pubmed
Filter :
Cancers (Basel)
Oncology

Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma

Learn more
Molecular & cellular Oncology
Oncology

From tumorigenesis to cell death: the aneuploidy paradox

Learn more
Breast Cancer research Treatment
Oncology

Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer

Learn more
Oncogene
Oncology

Targeted delivery of LXR-agonists to athd mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis

Learn more
Oncogene
Oncology

Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis

Learn more
Cancer Cell
Oncology

The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients

Learn more
Breast Cancer Research and Treatment
Oncology

Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis

Learn more
Cell
Oncology

Evolution of Metastases in Space and Time under Immune Selection.

Learn more
Cell Mol Gastroenterology Hepatology
Oncology

Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability.

Learn more
Oncotarget
Oncology

Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.

Learn more
Arteriosclerosis and Vascular Biology
Oncology

Hypoalphalipoproteinemia and BRAF(V600E) Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.

Learn more
The Lancet
Oncology

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Learn more